Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Bristol Myers Squibb (BMS) is a global biopharmaceutical company making advancements in oncology, haematology, immunology and cardiovascular disease. BMS are dedicated to helping patients prevail over serious diseases through a diverse and promising pipeline and new scientific platforms.

About the Oxford-BMS Research Alliance

The Oxford-Bristol Myers Squibb alliance was established in 2015 through our Translational Fellowship Programme, with the aim of stimulating new scientific discovery and translation and to generate a cohort of scientists that can navigate within and across both academic and industry spheres to bridge translational challenges. Oxford's alliance with Bristol Myers Squibb continues to grow year on year, the total of Oxford-Bristol Myers Squibb Fellows is now 34 and many other collaborative projects are currently running.

Bristol Myers Squibb (BMS) logo